Loading clinical trials...
Loading clinical trials...
Prospective Randomized Open Label Study to Compare the Efficacy and Safety of Ovarian Stimulation With Pergoveris® and Menopur® in Women With Severe Luteinizing Hormone (LH) and Follicular Stimulating Hormone (FSH) Deficiency.
Conditions
Interventions
Pergoveris: 150IU r-hFSH + 75IU r-hLH
Menopur: HMG-HP (150 IU)
Locations
1
Italy
Centro Riproduzione e Andrologia
Taranto, Italy, Italy
Start Date
March 1, 2011
Primary Completion Date
May 1, 2012
Completion Date
June 1, 2012
Last Updated
June 20, 2012
NCT01709331
NCT02908074
NCT01155518
NCT02310074
NCT02042638
Lead Sponsor
Centro Riproduzione e Andrologia
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions